{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "HKD", "regularMarketChangePercent": -1.0989065, "regularMarketPrice": 3.6, "earningsTimestamp": 1680101423, "earningsTimestampStart": 1680101423, "earningsTimestampEnd": 1680101423, "trailingAnnualDividendRate": 0.0, "trailingPE": 18.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": 0.2, "epsForward": 0.26, "epsCurrentYear": 0.22, "priceEpsCurrentYear": 16.363636, "sharesOutstanding": 3761669888, "bookValue": 2.867, "fiftyDayAverage": 3.67, "fiftyDayAverageChange": -0.07000017, "fiftyDayAverageChangePercent": -0.019073617, "twoHundredDayAverage": 3.07475, "twoHundredDayAverageChange": 0.52524996, "twoHundredDayAverageChangePercent": 0.17082688, "marketCap": 13652423680, "forwardPE": 13.846154, "priceToBook": 1.2556679, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "averageAnalystRating": "2.8 - Hold", "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1404869400000, "priceHint": 3, "marketState": "CLOSED", "exchange": "HKG", "shortName": "LUYE PHARMA", "longName": "Luye Pharma Group Ltd.", "messageBoardId": "finmb_9994690", "exchangeTimezoneName": "Asia/Hong_Kong", "exchangeTimezoneShortName": "HKT", "gmtOffSetMilliseconds": 28800000, "market": "hk_market", "esgPopulated": false, "regularMarketChange": -0.0400002, "regularMarketTime": 1683878916, "regularMarketDayHigh": 3.71, "regularMarketDayRange": "3.56 - 3.71", "regularMarketDayLow": 3.56, "regularMarketVolume": 33632000, "regularMarketPreviousClose": 3.64, "bid": 3.59, "ask": 3.6, "bidSize": 0, "askSize": 0, "fullExchangeName": "HKSE", "financialCurrency": "CNY", "regularMarketOpen": 3.71, "averageDailyVolume3Month": 17421733, "averageDailyVolume10Day": 15755030, "fiftyTwoWeekLowChange": 1.7199999, "fiftyTwoWeekLowChangePercent": 0.91489357, "fiftyTwoWeekRange": "1.88 - 4.65", "fiftyTwoWeekHighChange": -1.0500002, "fiftyTwoWeekHighChangePercent": -0.22580649, "fiftyTwoWeekLow": 1.88, "fiftyTwoWeekHigh": 4.65, "symbol": "2186.HK"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "No. 15 Chuang Ye Road", "address2": "High-tech Industrial Development Zone", "city": "Yantai", "zip": "264003", "country": "China", "website": "https://www.luye.cn", "industry": "Drug Manufacturers\u2014General", "industryDisp": "Drug Manufacturers\u2014General", "sector": "Healthcare", "longBusinessSummary": "Luye Pharma Group Ltd., an investment holding company, develops, produces, markets, and sells pharmaceutical products worldwide. The company offers Lipusu for ovarian and breast cancer; CMNa, a chemical sensitizer for cancer radiotherapy; Tiandida for ovarian or non-small cell lung cancer; Boyounuo, an injection for the treatment of various types of cancers and other solid tumors; and Xuezhikang, a lipid-regulating drug for the treatment of hypercholesterolaemia. It also provides Maitongna for cerebral edema swelling by trauma or surgery, and for venous reflux disorders; Beixi, an acarbose capsule for Type 2 diabetes; Rivastigmine Transdermal Patch for the treatment of Alzheimer's disease; Fentanyl Transdermal Patch for cancer pain; Buprenorphine Transdermal Patch for chronic pain; and Seroquel and Seroquel XR for the treatment of schizophrenia and manic episodes of bipolar affective disorders. In addition, the company offers Rykindo, an injection for the treatment of schizophrenia; Tiandixin used as an adjuvant therapy for malignant tumors, hydrothorax and ascites, and respiratory infections; Yitaida for acute promyelocytic leukemia and liver cancer; Lutingnuo, a glutathione injection for toxicity and injuries caused by ionizing radiation; and Beitangning, a pioglitazone hydrochloride capsule to control blood glucose. Further, it offers Nuosen for acute upper digestive tract hemorrhage; Sidinuo for osteoporosis; Glucosamine hydrochloride tablets for osteoarthritis; Oulai, a compound sodium aescinate gel for local swelling; Oukai for the treatment of soft tissue swelling and venous edema; and Fengshiye for patients who have pains in bones, joints, and limbs. The company distributes and sells pharmaceutical drugs; and manufactures and sells biopharmaceutical products. Luye Pharma Group Ltd. was founded in 1994 and is headquartered in Yantai, the People's Republic of China.", "fullTimeEmployees": 5005, "companyOfficers": [{"maxAge": 1, "name": "Mr. Dian Bo  Liu", "age": 56, "title": "Co-Founder, Exec. Chairman, CEO and Head of Corp. Directions & Strategies", "yearBorn": 1966, "fiscalYear": 2021, "totalPay": {"raw": 581777, "fmt": "581.78k", "longFmt": "581,777"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Rong Bing  Yang", "age": 56, "title": "Co-Founder & Vice Exec. Chairman", "yearBorn": 1966, "fiscalYear": 2021, "totalPay": {"raw": 422481, "fmt": "422.48k", "longFmt": "422,481"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Hui Xian  Yuan", "age": 63, "title": "Co-Founder & Exec. Director", "yearBorn": 1959, "fiscalYear": 2021, "totalPay": {"raw": 184402, "fmt": "184.4k", "longFmt": "184,402"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Yuan Yuan  Zhu", "age": 41, "title": "Exec. Director", "yearBorn": 1981, "fiscalYear": 2021, "totalPay": {"raw": 152658, "fmt": "152.66k", "longFmt": "152,658"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Yuan Chong  Liu", "age": 58, "title": "Chief Financial Officer", "yearBorn": 1964, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Yun Li  Xue", "age": 58, "title": "Sr. VP", "yearBorn": 1964, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Mei Yi  Lee ACIS, ACS, FCIS, FCS", "age": 54, "title": "Company Sec.", "yearBorn": 1968, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 6, "boardRisk": 4, "compensationRisk": 3, "shareHolderRightsRisk": 7, "overallRisk": 4, "governanceEpochDate": 1682899200, "compensationAsOfEpochDate": 1640908800, "maxAge": 86400}}], "error": null}}